SavedAdd your journal

Journals / Dicle Tıp Dergisi / 2011 / Cilt: 38 - Sayı: 4

Hemolytic uremic syndrome

Hemolitik üremik sendrom

Faruk ÖKTEM
AYÇA ESRA AKKAYA KUYBULU
Pages
519–525
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

In this review, we present the new classification of the disease, detailed information about pathogenesis, diagnostic methods and therapeutic approaches.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Haemolytic uremic syndrome (HUS) is a severe disease with microangiopathic anemia, thrombocytopenia and leading cause of acute renal failure in children.
📊
Key Findings & Data:Several etiological factors causing to HUS have been identified, like infections, genetic mutations, drugs, systemic diseases.
💡
Conclusion & Impact:In this review, we present the new classification of the disease, detailed information about pathogenesis, diagnostic methods and therapeutic approaches.
🔬Design:Review & Systematic Survey
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Haemolytic uremic syndrome (HUS) is a severe disease with microangiopathic anemia, thrombocytopenia and leading cause of acute renal failure in children. Several etiological factors causing to HUS have been identified, like infections, genetic mutations, drugs, systemic diseases. In this review, we present the new classification of the disease, detailed information about pathogenesis, diagnostic methods and therapeutic approaches.

Özet

Hemolitik üremik sendrom (HÜS) mikroanjiyopatik anemi, trombositopeni ve çocuklarda en sık akut böbrek yetmezliği nedenlerinden biri olan ciddi bir hastalıktır. Enfeksiyonlar, genetik mutasyonlar, ilaçlar, sistemik hastalıklar gibi HÜS’e sebep olan birçok mekanizma tanımlanmıştır. Bu derlemede, hastalığın yeni sınıflandırılmasını, patogenezi, tanı yöntemlerini ve tedavi yaklaşımlarını sunacağız.

🔖

Cite This Article

ÖKTEM, F., KUYBULU, A. E. A. (2011). Hemolytic uremic syndrome. Dicle Tıp Dergisi, Cilt: 38 - Sayı: 4, 519–525. https://ajindex.com/articles/349858

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (15)

  1. Besbas N, Karpman D, Landau D, et al. European Paediatric Research Group for HUS. A classification of hemolytic uremic syndrome and thrombotic thrombocytopenic purpura and related disorders. Kidney Int 2006;70(3):423-31
  2. Davis ID, Avner ED. Hemolityc uremic syndrome. In: Kliegman RM, Behrman RE, Jenson HB, et al. Nelson Textbook of Pediatrics, 18. edn. Saunders, An Imprint of Elsevier 2007:2181-3
  3. Johnson S, Taylor CM. Hemolytic Uremic Syndrome. In: Avner ED, Harmon WE, Niaudet P, Yoshikawa N, eds. Pediatric Nephrology, 6th edn. Berlin Heidelberg: Springer-Verlag, 2009:1155-81
  4. Palermo MS, Exeni RA, Fernández GC. Hemolytic uremic syndrome: pathogenesis and update of interventions. Expert Rev Anti Infect Ther 2009;7(6):697-707
  5. Scheiring J, Andreoli SP, Zimmerhackl LB. Treatment and outcome of Shiga-toxin-associated hemolytic uremic syndrome (HUS). Pediatr Nephrol 2008;23(10):1749-60
  6. Blackall DP, Marques MB. Hemolytic uremic syndrome revisited: Shiga toxin, factor H, and fibrin generation. Am J Clin Pathol 2004;121(Suppl):81-8
  7. Tarr PI. Shiga toxin-associated hemolytic uremic syndrome and thrombotic thrombocytopenic purpura: distinct mechanisms of pathogenesis. Kidney Int Suppl 2009;112(1):29-32
  8. Centers for Disease Control and Prevention (last update day: 26 July 2007) Hemolytic Uremic Syndrome, Post-diarrheal (HUS) http:// www.cdc.gov/ncphi/od/ai/casedef/ hemolyticcurrent.htm, son ulaşım tarihi: 23 Ağustos 2010 9. Brandt J, Wong C, Mihm S, et al. Invasive pneumococcal disease and hemolytic uremic syndrome. Pediatrics 2002;110(2):371-6
  9. Lee CF, Liu SC, Lue KH, Chen JP, Sheu JN. Pneumococcal pneumonia with empyema and hemolytic uremic syndrome in children: report of three cases. J Microbiol Immunol Infect 2006;39(4):348- 52
  10. Skerka C, Józsi M, Zipfel PF, Dragon-Durey MA, Fremeaux-Bacchi V. Autoantibodies in haemolytic uraemic syndrome (HUS). Thromb Haemost 2009;101(2):227-32
  11. Noris M, Remuzzi G. Atypical hemolytic-uremic syndrome. N Engl J Med 2009;361(17):1676-87
  12. Fang CJ, Richards A, Liszewski MK, Kavanagh D, Atkinson JP. Advances in understanding of pathogenesis of aHUS and HELLP. Br J Haematol 2008;143(3):336-48
  13. Loirat C, Noris M, Fremeaux-Bacchi V. Complement and the atypical hemolytic uremic syndrome in children. Pediatr Nephrol 2008;23(11):1957-72
  14. Kavanagh D, Goodship TH. Update on evaluating complement in hemolytic uremic syndrome. Curr Opin Nephrol Hypertens 2007;16(6):565-71
  15. Jokiranta TS, Zip